Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was partly due to its solid quarterly results ...

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. Patient monitoring companies within the ...

He’s a wild boy. Megan Fox’s ex-husband, Brian Austin Green, exposed the savage direct message MGK sent him on Instagram amid the actress’ pregnancy with the musician. “Stop asking when ...

The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

March 26, 2025 • Polo shirts, khaki shorts, and boat shoes: the classic uniform of elites on their days off. As our centennial series continues, Avery Trufelman, host of the podcast Articles of ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer. Field ...

Insulet Chief Technology Officer Mark Field left the company on Friday to pursue other opportunities, according to a Monday securities filing. Amit Guliani, Insulet’s group vice president of software ...